In last trading session, Nuvectis Pharma Inc (NASDAQ:NVCT) saw 69551.0 shares changing hands with its beta currently measuring 0.21. Company’s recent per share price level of $5.28 trading at $0.13 or 2.52% at ring of the bell on the day assigns it a market valuation of $102.01M. That closing price of NVCT’s stock is at a discount of -129.17% from its 52-week high price of $12.10 and is indicating a premium of 12.69% from its 52-week low price of $4.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.36 million shares which gives us an average trading volume of 174.06K if we extend that period to 3-months.

Nuvectis Pharma Inc (NASDAQ:NVCT) trade information

Upright in the green during last session for gaining 2.52%, in the last five days NVCT remained trading in the green while hitting it’s week-highest on Wednesday, 11/27/24 when the stock touched $5.28 price level, adding 1.31% to its value on the day. Nuvectis Pharma Inc’s shares saw a change of -36.69% in year-to-date performance and have moved 4.14% in past 5-day. Nuvectis Pharma Inc (NASDAQ:NVCT) showed a performance of -32.91% in past 30-days. Number of shares sold short was 1.39 million shares which calculate 4.74 days to cover the short interests.

Nuvectis Pharma Inc (NVCT) estimates and forecasts

Statistics highlight that Nuvectis Pharma Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -17.50% of value to its shares in past 6 months, showing an annual growth rate of 29.37% while that of industry is 17.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Nuvectis Pharma Inc (NASDAQ:NVCT)’s Major holders

Insiders are in possession of 51.52% of company’s total shares while institution are holding 6.98 percent of that, with stock having share float percentage of 14.39%. Investors also watch the number of corporate investors in a company very closely, which is 6.98% institutions for Nuvectis Pharma Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at NVCT for having 0.25 million shares of worth $1.59 million. And as of 2024-06-30, it was holding 1.5166 of the company’s outstanding shares.

The second largest institutional holder is BALDWIN BROTHERS LLC/MA, which was holding about 0.17 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0183 of outstanding shares, having a total worth of $1.07 million.